Global Diabetic Retinopathy Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Diabetic Retinopathy Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 Laser Surgery
1.3.3 Injection of Corticosteroids
1.3.4 Anti-VEGF Drugs
1.3.5 Vitrectomy
1.4 Market by Application
1.4.1 Global Diabetic Retinopathy Market Share by Application: 2020 VS 2026
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Retinopathy Market Perspective (2015-2026)
2.2 Diabetic Retinopathy Growth Trends by Regions
2.2.1 Diabetic Retinopathy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetic Retinopathy Historic Market Share by Regions (2015-2020)
2.2.3 Diabetic Retinopathy Forecasted Market Size by Regions (2021-2026)
2.3 Diabetic Retinopathy Industry Dynamic
2.3.1 Diabetic Retinopathy Market Trends
2.3.2 Diabetic Retinopathy Market Drivers
2.3.3 Diabetic Retinopathy Market Challenges
2.3.4 Diabetic Retinopathy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Retinopathy Players by Market Size
3.1.1 Global Top Diabetic Retinopathy Players by Revenue (2015-2020)
3.1.2 Global Diabetic Retinopathy Revenue Market Share by Players (2015-2020)
3.2 Global Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Retinopathy Revenue
3.4 Global Diabetic Retinopathy Market Concentration Ratio
3.4.1 Global Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy Revenue in 2019
3.5 Key Players Diabetic Retinopathy Area Served
3.6 Key Players Diabetic Retinopathy Product Solution and Service
3.7 Date of Enter into Diabetic Retinopathy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Retinopathy Breakdown Data by Type
4.1 Global Diabetic Retinopathy Historic Market Size by Type (2015-2020)
4.2 Global Diabetic Retinopathy Forecasted Market Size by Type (2021-2026)
5 Diabetic Retinopathy Breakdown Data by Application
5.1 Global Diabetic Retinopathy Historic Market Size by Application (2015-2020)
5.2 Global Diabetic Retinopathy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diabetic Retinopathy Market Size (2015-2026)
6.2 North America Diabetic Retinopathy Market Size by Type (2015-2020)
6.3 North America Diabetic Retinopathy Market Size by Application (2015-2020)
6.4 North America Diabetic Retinopathy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Diabetic Retinopathy Market Size (2015-2026)
7.2 Europe Diabetic Retinopathy Market Size by Type (2015-2020)
7.3 Europe Diabetic Retinopathy Market Size by Application (2015-2020)
7.4 Europe Diabetic Retinopathy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Retinopathy Market Size (2015-2026)
8.2 Asia-Pacific Diabetic Retinopathy Market Size by Type (2015-2020)
8.3 Asia-Pacific Diabetic Retinopathy Market Size by Application (2015-2020)
8.4 Asia-Pacific Diabetic Retinopathy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Diabetic Retinopathy Market Size (2015-2026)
9.2 Latin America Diabetic Retinopathy Market Size by Type (2015-2020)
9.3 Latin America Diabetic Retinopathy Market Size by Application (2015-2020)
9.4 Latin America Diabetic Retinopathy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Retinopathy Market Size (2015-2026)
10.2 Middle East & Africa Diabetic Retinopathy Market Size by Type (2015-2020)
10.3 Middle East & Africa Diabetic Retinopathy Market Size by Application (2015-2020)
10.4 Middle East & Africa Diabetic Retinopathy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Diabetic Retinopathy Introduction
11.1.4 Bayer Revenue in Diabetic Retinopathy Business (2015-2020))
11.1.5 Bayer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Diabetic Retinopathy Introduction
11.2.4 Roche Revenue in Diabetic Retinopathy Business (2015-2020)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Diabetic Retinopathy Introduction
11.3.4 Novartis Revenue in Diabetic Retinopathy Business (2015-2020)
11.3.5 Novartis Recent Development
11.4 TEVA
11.4.1 TEVA Company Details
11.4.2 TEVA Business Overview
11.4.3 TEVA Diabetic Retinopathy Introduction
11.4.4 TEVA Revenue in Diabetic Retinopathy Business (2015-2020)
11.4.5 TEVA Recent Development
11.5 Alimera Sciences
11.5.1 Alimera Sciences Company Details
11.5.2 Alimera Sciences Business Overview
11.5.3 Alimera Sciences Diabetic Retinopathy Introduction
11.5.4 Alimera Sciences Revenue in Diabetic Retinopathy Business (2015-2020)
11.5.5 Alimera Sciences Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Diabetic Retinopathy Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020)
11.6.5 Regeneron Pharmaceuticals Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Diabetic Retinopathy Introduction
11.7.4 Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2015-2020)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Kowa Group
11.8.1 Kowa Group Company Details
11.8.2 Kowa Group Business Overview
11.8.3 Kowa Group Diabetic Retinopathy Introduction
11.8.4 Kowa Group Revenue in Diabetic Retinopathy Business (2015-2020)
11.8.5 Kowa Group Recent Development
11.9 Ohr Pharmaceutical
11.9.1 Ohr Pharmaceutical Company Details
11.9.2 Ohr Pharmaceutical Business Overview
11.9.3 Ohr Pharmaceutical Diabetic Retinopathy Introduction
11.9.4 Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2015-2020)
11.9.5 Ohr Pharmaceutical Recent Development
11.10 Quark Pharmaceuticals
11.10.1 Quark Pharmaceuticals Company Details
11.10.2 Quark Pharmaceuticals Business Overview
11.10.3 Quark Pharmaceuticals Diabetic Retinopathy Introduction
11.10.4 Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020)
11.10.5 Quark Pharmaceuticals Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Diabetic Retinopathy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Laser Surgery
Table 3. Key Players of Injection of Corticosteroids
Table 4. Key Players of Anti-VEGF Drugs
Table 5. Key Players of Vitrectomy
Table 6. Global Diabetic Retinopathy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Diabetic Retinopathy Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Diabetic Retinopathy Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Diabetic Retinopathy Market Share by Regions (2015-2020)
Table 10. Global Diabetic Retinopathy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Diabetic Retinopathy Market Share by Regions (2021-2026)
Table 12. Diabetic Retinopathy Market Market Trends
Table 13. Diabetic Retinopathy Market Drivers
Table 14. Diabetic Retinopathy Market Challenges
Table 15. Diabetic Retinopathy Market Restraints
Table 16. Global Diabetic Retinopathy Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Diabetic Retinopathy Market Share by Players (2015-2020)
Table 18. Global Top Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Retinopathy as of 2019)
Table 19. Global Diabetic Retinopathy by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Diabetic Retinopathy Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetic Retinopathy Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Diabetic Retinopathy Revenue Market Share by Type (2015-2020)
Table 25. Global Diabetic Retinopathy Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 26. Global Diabetic Retinopathy Market Size Share by Application (2015-2020) (US$ Million)
Table 27. Global Diabetic Retinopathy Revenue Market Share by Application (2015-2020)
Table 28. Global Diabetic Retinopathy Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 29. North America Diabetic Retinopathy Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Diabetic Retinopathy Market Share by Type (2015-2020)
Table 31. North America Diabetic Retinopathy Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Diabetic Retinopathy Market Share by Application (2015-2020)
Table 33. North America Diabetic Retinopathy Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Diabetic Retinopathy Market Share by Country (2015-2020)
Table 35. Europe Diabetic Retinopathy Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Diabetic Retinopathy Market Share by Type (2015-2020)
Table 37. Europe Diabetic Retinopathy Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Diabetic Retinopathy Market Share by Application (2015-2020)
Table 39. Europe Diabetic Retinopathy Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Diabetic Retinopathy Market Share by Country (2015-2020)
Table 41. Asia-Pacific Diabetic Retinopathy Market Size by Type (2015-2020) (US$ Million)
Table 42. Asia-Pacific Diabetic Retinopathy Market Share by Type (2015-2020)
Table 43. Asia-Pacific Diabetic Retinopathy Market Size by Application (2015-2020) (US$ Million)
Table 44. Asia-Pacific Diabetic Retinopathy Market Share by Application (2015-2020)
Table 45. Asia-Pacific Diabetic Retinopathy Market Size by Region (US$ Million) (2015-2020)
Table 46. Asia-Pacific Diabetic Retinopathy Market Share by Region (2015-2020)
Table 47. Latin America Diabetic Retinopathy Market Size by Type (2015-2020) (US$ Million)
Table 48. Latin America Diabetic Retinopathy Market Share by Type (2015-2020)
Table 49. Latin America Diabetic Retinopathy Market Size by Application (2015-2020) (US$ Million)
Table 50. Latin America Diabetic Retinopathy Market Share by Application (2015-2020)
Table 51. Latin America Diabetic Retinopathy Market Size by Country (US$ Million) (2015-2020)
Table 52. Latin America Diabetic Retinopathy Market Share by Country (2015-2020)
Table 53. Middle East & Africa Diabetic Retinopathy Market Size by Type (2015-2020) (US$ Million)
Table 54. Middle East & Africa Diabetic Retinopathy Market Share by Type (2015-2020)
Table 55. Middle East & Africa Diabetic Retinopathy Market Size by Application (2015-2020) (US$ Million)
Table 56. Middle East & Africa Diabetic Retinopathy Market Share by Application (2015-2020)
Table 57. Middle East & Africa Diabetic Retinopathy Market Size by Country (US$ Million) (2015-2020)
Table 58. Middle East & Africa Diabetic Retinopathy Market Share by Country (2015-2020)
Table 59. Bayer Company Details
Table 60. Bayer Business Overview
Table 61. Bayer Diabetic Retinopathy Product
Table 62. Bayer Revenue in Diabetic Retinopathy Business (2015-2020) (US$ Million)
Table 63. Bayer Recent Development
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Diabetic Retinopathy Product
Table 67. Roche Revenue in Diabetic Retinopathy Business (2015-2020) (US$ Million)
Table 68. Roche Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Diabetic Retinopathy Product
Table 72. Novartis Revenue in Diabetic Retinopathy Business (2015-2020) (US$ Million)
Table 73. Novartis Recent Development
Table 74. TEVA Company Details
Table 75. TEVA Business Overview
Table 76. TEVA Diabetic Retinopathy Product
Table 77. TEVA Revenue in Diabetic Retinopathy Business (2015-2020) (US$ Million)
Table 78. TEVA Recent Development
Table 79. Alimera Sciences Company Details
Table 80. Alimera Sciences Business Overview
Table 81. Alimera Sciences Diabetic Retinopathy Product
Table 82. Alimera Sciences Revenue in Diabetic Retinopathy Business (2015-2020) (US$ Million)
Table 83. Alimera Sciences Recent Development
Table 84. Regeneron Pharmaceuticals Company Details
Table 85. Regeneron Pharmaceuticals Business Overview
Table 86. Regeneron Pharmaceuticals Diabetic Retinopathy Product
Table 87. Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020) (US$ Million)
Table 88. Regeneron Pharmaceuticals Recent Development
Table 89. Boehringer Ingelheim Company Details
Table 90. Boehringer Ingelheim Business Overview
Table 91. Boehringer Ingelheim Diabetic Retinopathy Product
Table 92. Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2015-2020) (US$ Million)
Table 93. Boehringer Ingelheim Recent Development
Table 94. Kowa Group Business Overview
Table 95. Kowa Group Diabetic Retinopathy Product
Table 96. Kowa Group Company Details
Table 97. Kowa Group Revenue in Diabetic Retinopathy Business (2015-2020) (US$ Million)
Table 98. Kowa Group Recent Development
Table 99. Ohr Pharmaceutical Company Details
Table 100. Ohr Pharmaceutical Business Overview
Table 101. Ohr Pharmaceutical Diabetic Retinopathy Product
Table 102. Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2015-2020) (US$ Million)
Table 103. Ohr Pharmaceutical Recent Development
Table 104. Quark Pharmaceuticals Company Details
Table 105. Quark Pharmaceuticals Business Overview
Table 106. Quark Pharmaceuticals Diabetic Retinopathy Product
Table 107. Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020) (US$ Million)
Table 108. Quark Pharmaceuticals Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Diabetic Retinopathy Market Share by Type: 2020 VS 2026
Figure 2. Laser Surgery Features
Figure 3. Injection of Corticosteroids Features
Figure 4. Anti-VEGF Drugs Features
Figure 5. Vitrectomy Features
Figure 6. Global Diabetic Retinopathy Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Diabetic Retinopathy Report Years Considered
Figure 11. Global Diabetic Retinopathy Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Diabetic Retinopathy Market Share by Regions: 2020 VS 2026
Figure 13. Global Diabetic Retinopathy Market Share by Regions (2021-2026)
Figure 14. Global Diabetic Retinopathy Market Share by Players in 2019
Figure 15. Global Top Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Retinopathy as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Diabetic Retinopathy Revenue in 2019
Figure 17. North America Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Diabetic Retinopathy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Bayer Revenue Growth Rate in Diabetic Retinopathy Business (2015-2020)
Figure 43. Roche Revenue Growth Rate in Diabetic Retinopathy Business (2015-2020)
Figure 44. Novartis Revenue Growth Rate in Diabetic Retinopathy Business (2015-2020)
Figure 45. TEVA Revenue Growth Rate in Diabetic Retinopathy Business (2015-2020)
Figure 46. Alimera Sciences Revenue Growth Rate in Diabetic Retinopathy Business (2015-2020)
Figure 47. Regeneron Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2015-2020)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Diabetic Retinopathy Business (2015-2020)
Figure 49. Kowa Group Revenue Growth Rate in Diabetic Retinopathy Business (2015-2020)
Figure 50. Ohr Pharmaceutical Revenue Growth Rate in Diabetic Retinopathy Business (2015-2020)
Figure 51. Quark Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed